Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Ductal, Breast”

464 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 464 results

Not applicableWithdrawnNCT01729832
What this trial is testing

Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituRecurrent Breast Cancer+7 more
Ohio State University Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06868238
What this trial is testing

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

Who this might be right for
Ductal Carcinoma in Situ
University of Florida 30
Large-scale testing (Phase 3)UnknownNCT01126138
What this trial is testing

Capecitabine (NX) Versus Docetaxel Plus Capecitabine (TX) as 1-line Chemotherapy on Metastatic Breast Cancer (MBC)

Who this might be right for
Carcinoma, Invasive Ductal, Breast
Chinese Academy of Medical Sciences 200
Not applicableActive Not RecruitingNCT02889458
What this trial is testing

Hong Kong Breast Cancer Study

Who this might be right for
Breast CancerDuctal Carcinoma In Situ
The University of Hong Kong 7,000
Testing effectiveness (Phase 2)WithdrawnNCT02336984
What this trial is testing

A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Early research (Phase 1)Not Yet RecruitingNCT07360314
What this trial is testing

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
EMD Serono Research & Development Institute, Inc. 138
Not applicableStudy completedNCT03664778
What this trial is testing

Abbreviated Breast MRI After Cancer Treatment

Who this might be right for
Breast NeoplasmsCarcinoma, Intraductal, Noninfiltrating
University of Pennsylvania 184
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Not applicableActive Not RecruitingNCT04225585
What this trial is testing

Well-Being After Breast Cancer Surgery

Who this might be right for
Coping Skills Training for Persistent Post-Surgical PainGeneral Health Education
Duke University 316
Testing effectiveness (Phase 2)Study completedNCT02199418
What this trial is testing

Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 132
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Not applicableStudy completedNCT03834532
What this trial is testing

Living Well After Breast Surgery

Who this might be right for
Breast Cancer FemaleStage I Breast CancerStage II Breast Cancer+4 more
University of Texas at Austin 17
Testing effectiveness (Phase 2)Ended earlyNCT01388777
What this trial is testing

Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT00126464
What this trial is testing

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 100
Not applicableStudy completedNCT00390962
What this trial is testing

The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)

Who this might be right for
StrokeTransient Ischemic Attack
University Hospital, Basel, Switzerland 469
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
ITM Oncologics GmbH 270
Testing effectiveness (Phase 2)Study completedNCT00290745
What this trial is testing

Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
University of California, San Francisco 79
Load More Results